Key facts
| Price (PPV) | 150 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | irbésartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09CA04 |
| Manufacturer | COOPER PHARMA |
| Presentation | Boite de 28 |
| Nature | Médicament |
| Hospital price | 93.70 MAD |
| Data collected on | 9/8/2026 |
Indications
L’irbersartan est indiqué chez l’adulte dans le traitement de l’ hypertension artérielle essentielle. Il est également indiqué dans le traitement de l’atteinte rénale chez les patients adultes hypertendus diabétiques de type 2, dans le cadre de la prise en charge par un médicament antihypertenseur.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Arapro 300 mg (ZENITH PHARMA) contains the same active substance as Icard 300 mg (Irbésartan) at the same strength, but in a different pack: Boite de 10 at 60 MAD, i.e. 6 MAD per unit against 5.36 MAD for Icard 300 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Irvel 300 mg | AFRIC-PHAR | Boite de 28 | 150 MAD | 5.36 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Arapro 300 mg | ZENITH PHARMA | Boite de 10 | 60 MAD | 6 / unit |
| Irphi 300 mg | PHI | Boite de 10 | 60.70 MAD | 6.07 / unit |
| Irvel 300 mg | AFRIC-PHAR | Boite de 14 | 84 MAD | 6 / unit |
| Vepran 300 mg | SOTHEMA | Boite de 14 | 84 MAD | 6 / unit |
| Irphi 300 mg | PHI | Boite de 20 | 109.70 MAD | 5.49 / unit |
| Novortan 300 mg | NOVOPHARMA | Boite de 30 | 145 MAD | 4.83 / unit |
| Avacor 300 mg | POLYMEDIC | Boite de 30 | 160 MAD | 5.33 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Icard 300 mg
Icard 300 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by COOPER PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Icard 300 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Icard 300 mg
Answers to common questions from Moroccan patients about this drug.